🟢 EIQ.AX is trading 37.9% up today on FDA heart-failure decision anticipation and AI diagnostic momentum

EIQ.AX is trading 37.9% up today at A$1.71 as investors react to upcoming regulatory milestones and renewed interest in the company's AI-driven cardiac diagnostic platform.

• Market focus is centered on a looming FDA decision for Echo IQ’s heart-failure AI tool, building on the momentum of its previously cleared aortic stenosis diagnostic technology.
• Speculative interest is being driven by commercial pipeline progress and high insider ownership, leading to a significant repricing as investors target high-growth ASX medical technology assets.